FDA and Johnson & Johnson

Ben discusses the FDA's delays and Johnson & Johnson's submission for a single-shot COVID-19 vaccine. Highlighting the potential impact of this new vaccine on the pandemic response, Ben questions the FDA's timing amidst the urgency of the situation.